Introduction
Introduction

Diabetes mellitus (DM) is a major risk factor for the development of cardiovascular diseases that are commonly grouped into microvascular diseases (like retinopathy, nephropathy and neuropathy) and macrovascular disorders (including ischaemic heart disease, peripheral vascular and cerebrovascular diseases)
.
However, the macrovascular complications are the major contributors to the morbidity and mortality in diabetes and are associated with high incidence of cardiovascular diseases including stroke [6] , myocardial infarction [7] and diabetic foot ulceration [8] . Although the mechanisms for the development of diabetic macrovasculopathy are complex and remain poorly understood, one of the key components is considered to be endothelial dysfunction and impaired vascular repair and regeneration with inadequate collateral vascular formation [9, 10] . Improving endothelial function and angiogenesis could serve as a new important therapeutic strategy for diabetic macrovascular diseases.
Vascular endothelial growth factor (VEGF) plays a critical role in the function and structural integrity of endothelial cells and angiogenesis [11, 12] . Bone marrow mesenchymal stem cells and other progenitor cells are important sources of VEGF [13, 14] . [15, 16] . [17] [18] [19] . [20, 21] . [22] .
Recently, bone marrow mesenchymal stem cells including multipotent adult progenitor cells (MAPCs) have been shown to promote vascular regeneration, enhance neovascularization and improve myocardial function in the setting of ischaemic injury at least partially through their paracrine/autocrine actions including secretion of VEGF after cellular transplantation
Signal transducer and activator of transcription 3 (STAT3) is a member of the STATs family and is expressed in a variety of normal cells (such as B cells, endothelial cells, cardiomyctes and bone marrow stem cells) and cancer cells (like M1 leukaemia cells)
STAT3 is activated when it is phosphorylated at tyrosine 705 by janus-activated kinase (JAK) like JAK2, leading to the dimerization of STAT3 followed by translocation into nucleus and initiation of various biological responses
STAT3 signalling is important in the regulation of VEGF expression and function in vascular endothelial cells and cardiac myocytes as well as cancer cells
On the other hand, existing evidence suggests that VEGF also promotes the activation of STAT3 in vascular endothelial cells [23, 24] , indicating an interactive relationship between STAT3 and VEGF. Recently, it is reported that STAT3 signalling mediates VEGF production in mouse bone marrow stem cells [19] . VEGF expression in bone marrow mesenchymal stem cells is also reported to be enhanced when Akt is overexpressed in the cells [25] . Adult bone marrow multipotent progenitor cells (MAPCs) are a type of special cells that are isolated and cultured from postnatal human and rodent tissues including bone marrow, muscle and brain [26] [27] [28] . These cells have been well characterized and are able to differentiate into multiple cell lineages including endothelial cells and neurons [27, 28] . MAPCs have been shown to secret VEGF and significantly contribute to the angiogenesis and revascularization in the setting of ischaemia [29] 
Materials and methods
Dulbecco
Cell culture
Rat MAPCs (rMAPCs) were isolated and cultured as previously described [28] . After (Fig. 2C) . These data suggested that suppression of VEGF production by high level of D-glucose was not secondary to HO. (Fig. 3B) . However, when D-glucose concentration was increased to 50 mM or above, the proliferation rate of rMAPCs was significantly decreased as shown in Fig. 3C Fig. 4A and B, suggesting that Akt expression and activation were not affected by HG or HO. 24 hrs. The tyrosine phosphorylation of both JAK2 (Fig. 5A and C) and STAT3 (Fig. 5B and D 
Apoptosis assay
Results
Effects of HG on VEGF expression in rMAPCs
Effects of HG on apoptosis and proliferation of rMAPCs
Fig. 1 High glucose suppresses VEGF expression in rMAPCs independent of hyperosmolarity. (A) VEGF mRNA level was significantly decreased in rMAPCs when exposed to 30 mM D-glucose for 24 hrs as analysed using real-time PCR. (B) The amount of VEGF protein released in the rMAPCsconditioned media was dramatically reduced to undetectable level as measured by ELISA after 48 hrs of incubation with 30 mM D-glucose.
NG: rMAPCs were incubated in the media with 5.5 mM D-glucose (normal media); HG: rMAPCs were incubated in the media with 30 mM D-glucose; and HO: rMAPCs were incubated in the media with 24.5 mM mannitol (hyperosmalarity). *P Ͻ 0.01 compared with NG (5.5 mM D-glucose), n ϭ 4.
Fig. 2 Effect of high glucose on intracellular production of VEGF in rMAPCs. Intracellular accumulation of VEGF in rMAPCs was significantly decreased by high glucose independent of hyperosmolarity as evaluated by immunofluorescence staining after 24 hrs of incubation with 30 mM D-glucose. NG: rMAPCs were incubated in the media with 5.5 mM D-glucose (normal); HG: rMAPCs were incubated in the media with 30 mM D-glucose; and HO: rMAPCs were incubated in the media with 24.5 mM mannitol. experimental conditions when their concentrations are below 50 mM, and that the reduction of VEGF production by HG is indeed not due to reduced cell proliferation or increased cell apoptosis.
Effects of HG on Akt phosphorylation in rMAPCs
To determine whether Akt phosphorylation in rMAPCs was affected by HG, the cells were cultured in the media with NG (5.5 mM) or HG (30 mM) or high osmolarity with mannitol (30 mM). Western immunoblot analysis demonstrated that the total and phosphorylated Akt levels in rMAPCs were the same for all three groups as shown in
Fig. 3 Effect of high glucose on the apoptosis and proliferation of rMAPCs. The rates of apoptosis (A) and proliferation (B) of rMAPCs were not affected by high glucose (30 mM D-glucose) or hyperosmolarity after 48 hrs incubation as evaluated by flow cytometry and BrdU colorimetric immunoassay, respectively. However, the cell proliferation rate was significantly decreased when the cells were incubated with 50 mM D-glucose (C).
NG: rMAPCs were incubated in the media with 5.5 mM D-glucose; HG: rMAPCs were incubated in the media with 30 mM D-glucose; and HO: rMAPCs were incubated in the media with 24.5 mM mannitol.
Fig. 4 The expression and activation of Akt in rMAPCs were not altered by high glucose or hyperosmolarity after 48 hrs incubation as analysed by Western blot. (A) Representative Western blot for Akt (both total and phosphorylated). (B) Bar graph showing the relative band intensity of the tyrosine-phosphorylated
Effects of HG on nuclear translocation of phosphorylated STAT3 in rMAPCs
STAT3 phosphorylation at tyrosine 705 followed by nuclear translocation is required to initiate various biological responses [20, 21] Fig. 6A, confirming (Fig. 6C) . However, the phosphorylated STAT3 protein content was dramatically decreased in the cytoplasma and nuclei of rMAPCs cultured in the media with high D-glucose of 30 mM (Fig. 6B) , further confirming that STAT3 phosphorylation and its subsequent nuclear translocation were suppressed by HG. (Fig. 7A and B 
. Rat MAPCs cultured in normal media with D-glucose concentration of 5.5 mM for 24 hrs showed the presence of significant amount of phosphorylated STAT3 (skyblue) in the cytoplasma and nuclei (blue) as shown in
Effects of AG490 on JAK2/STAT3 signalling and VEGF expression in rMAPCs
Discussion
Cardiovascular dysfunction is a major and yet challenging complication in the patients with DM with reduction in coronary collateral vessel formation and angiogenesis [31, 32] . The mechanisms are complex and still poorly defined. VEGF plays an essential role in the processes of angiogenesis and maintenance of endothelial integrity (both structurally and functionally) [11, 12] [13, 19, [33] [34] [35] . In the present study, we showed that rMAPCs produced a significant amount of VEGF in culture that was confirmed by both mRNA transcription and protein expression. These cells may represent an important source of VEGF especially in the setting of cellular therapy for ischaemic diseases when bone marrow stem cells are delivered in the ischaemic areas like myocardial infarction [14, 36] . This may provide a molecular explanation (at least in part) for the beneficial effects of bone marrow stem cell transplantation in experimental ischaemic animal models [15, 16, 37] [39] . In addition to bone marrow, MAPCs were present in many tissues including fat tissue, muscle and brain [40] . The initial release of VEGF from the local ischaemic tissue (like muscle) may be important to tissue regeneration and repair since VEGF helps to recruit bone marrow-derived progenitor cells to ischaemic tissue [41] . Once the bone marrow progenitor cells arrive at the ischaemic area, they produce more VEGF, and in The regulation of VEGF expression or production is complex and involves many factors, including (but not limited to) hypoxia, nitric oxide and TGF-b [26, 42, 43] . STAT3 is an important regulator for the expression of VEGF in cardiac myocytes, bone marrow mesenchymal stem cells and the majority of malignant cells [19, 44, 45] . Activation of STAT3 enhances the transcription of VEGF promoter in cancer cells [46] , thus leading to an increased production of VEGF and promotion of endothelial cell proliferation, migration and vascular formation [44] . Interestingly, VEGF also stimulates tyrosine phosphorylation of STAT3 rapidly and induces its nuclear translocation in endothelial cells [23, 24] . Thus, bidirectional interactions are present between STAT3 and VEGF.
. In the present study, we demonstrated for the first time that HG suppressed VEGF expression and inhibited JAK2/STAT3 signalling pathway in rMAPCs. VEGF is expressed in many different cell types including cardiomyocytes, fibroblasts, retinal percytes and bone marrow mesenchymal stem cells as well as human bone marrow-derived progenitor cells
Plasma VEGF is elevated in DM patients in general [47] . However, the vascular responses to hyperglycemia in diabetic microvascular diseases and macrovascular disorders are totally opposite (increased neovascularization versus decreased vascular formation) [1] [2] [3] [4] [5] . This mystery is explained at least partially by the finding that VEGF and its receptors are differentially expressed in different organ systems in DM [35] . Thus 
